Cell And Gene Therapy Manufacturing

  1. Perfusion: Medium Selection And Testing 6/16/2025

    An examination of what to consider in a perfusion medium, including varying reconstituted concentrations, supporting multiple cell clones, allowing for high cell densities at low medium exchange rates, and using it in various types of perfusion.

  2. Perfusion: Planning A Run 6/16/2025

    Learn about a logical approach for defining the operation of a perfusion run. We will break down the process using the three following steps: knowledge space, design space, and control space.

  3. How To Fill And Empty Nunc Standard Cell Factory System 3/21/2022

    Watch this step by step how to instructional video to learn how to fill and empty the Thermo Scientific Nunc Standard Cell Factory System, which is compatible with the same cell culture techniques used in smaller cell culture vessels.

  4. Accelerating Cell Culture Media Manufacturing: From Rapid Prototyping Through cGMP 6/5/2025

    Industry leaders addressing effective ways to help streamline media manufacturing, including rapid small scale non-cGMP media prototyping and proprietary media formulation outsourcing options.

  5. CMC Comparability: Transitioning to Commercial Manufacturing with Dr. Nicole Verdun 1/30/2024

    In this segment, Dr. Nicole Verdun shares some of the challenges demonstrating CMC comparability during late-stage product development (i.e., pivotal or Phase 3 clinical trial) that occur while transitioning to commercial manufacturing.

  6. Cytovance And Thermo Fisher Scientific Single-Use Equipment Collaboration 11/10/2025

    This video highlights the success Cytovance has had solving complex issues with our Thermo Scientific imPULSE Single-Use Mixers (S.U.M.s) HyPerforma Single-Use Fermentors (S.U.F.s) and BioProcess Containers (BPCs).

  7. Manufacturing Hurdles With Viral Vectors 11/13/2023

    With a wide range of viral vector-based drugs already approved, viral vectors are expected to remain the primary delivery mechanism for the foreseeable future. However, as the demand for viral vectors increases, addressing the challenges related to their manufacture and scale-up is critical. In this segment, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO share what they consider to be the most difficult challenges in vector development and manufacturing currently.

  8. Major Trends Impacting Allogeneic Cell Therapies For Oncology 5/6/2024

    We kicked off this Cell & Gene Live, Unlocking the Future of Allogeneic Cell Therapy for Oncology by discussing the major trends impacting allogeneic cell therapies for oncology.

  9. Ensure Consistency Across Batches With A Powerful Tool 5/19/2025

    Learn how to streamline bioprocess control with an innovative software's Unit Save and Load feature. Save configurations, reduce setup time, and ensure consistency across batches with this powerful tool.

  10. Major Advancements In mRNA 1/29/2024

    Experts on this Cell & Gene live event discuss the major scientific biological advances in understanding the potential for mRNA-based immunotherapies vaccines for cancer over the last 2 years.